https://doi.org/10.55788/2a0dd619
SURGICAL-AF 2 (NCT05509517) is a pragmatic, open-label, multicentre, randomised clinical trial in participants with coronary artery bypass graft surgery (CABG) or valve surgery. Participants were randomised 1:1 to either photoplethysmography-based smartphone rhythm monitoring or usual care (which entailed no mandated rhythm monitoring), with physician follow-up after 21–91 days [1]. The primary endpoint was atrial fibrillation management (a composite of initiation of oral anticoagulation, cardioversion, up-titration or initiation of antiarrhythmic drugs, and implantation of a cardiac implantable electronic device) if this was required due to detection of post-operative atrial fibrillation or atrial flutter.
The intervention group included 238 participants and 212 participants were included in the usual care group. During the follow-up period, 1.9% of participants in the usual care group had detected atrial fibrillation or atrial flutter compared with 18.5% of participants in the intervention group (OR 11.8; 95% CI 4.2–33.3). The primary endpoint was met in 24 (10.1%) participants in the intervention group versus 5 (2.4%) participants in the usual care group (OR 5.1; 95% CI 1.8–14.4). This outcome was driven by the initiation of anticoagulation in 17 (7.1%) participants in the intervention group versus 3 (1.4%) participants in the usual care group (OR 5.4; 95% CI 1.5–18.5). No device implantation occurred during the study.
“Photoplethysmography-based smartphone monitoring increases the detection of atrial fibrillation or atrial flutter, which led to a 5-fold increase in atrial fibrillation management interventions,” concluded Dr Henri Gruwez (Hospital Oost-Limburg, Belgium).
- Gruwez H, et al. Impact of photoplethysmography-based smartphone rhythm monitoring on atrial fibrillation detection and management after cardiac surgery: a pragmatic randomized trial. Atrial fibrillation: stroke - oral anticoagulants. EHRA Congress 2024, 7–9 April, Berlin, Germany.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay Next Article
Factors associated with negative outcomes in post-operative atrial fibrillation »
« SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay Next Article
Factors associated with negative outcomes in post-operative atrial fibrillation »
Table of Contents: EHRA 2024
Featured articles
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Personalising Ablation Techniques
Ablate-by-LAW: CT-determined left atrial wall thickness for ablation titration in atrial fibrillation
Personalised LAWT-guided ablation non-inferior to CLOSE protocol for paroxysmal atrial fibrillation
Style-AF: Improved outcomes with vascular closure versus figure-of-eight suture
Advantage of PREVENTIVE ablation plus implantable cardioverter-defibrillator in ischaemic cardiomyopathy
ASTRO AF: No benefit of staged left atrial appendage isolation cryoballoon ablation over radiofrequency ablation
Innovative Ablation Strategies
Pulsed-field ablation vs high-power short-duration radiofrequency in paroxysmal AF
CryoCure-VT: Endocardial ultra-low temperature cryoablation effective in sustained monomorphic ventricular tachycardia
PIRECNA: Cardioneuroablation is feasible for vagally-induced atrioventricular block
MRI head-to-head comparison of lesion quality following various ablation techniques
“Single-shot” conformable catheter shows promising efficacy in paroxysmal atrial fibrillation
Post-Ablation Recurrence
AF burden versus classical AF classification in predicting arrhythmia recurrence
ARTESiA: Stroke risk unaffected by subclinical atrial fibrillation duration
Ablation strategy and the number of repeat procedures not associated with atrial fibrillation recurrence
Factors associated with negative outcomes in post-operative atrial fibrillation
Arrhythmia Technologies
Smartphone rhythm monitoring optimises AF management following cardiac surgery
SMART-AV and SMART-CRT: Improved cardiac outcomes with algorithm-adapted atrioventricular delay
Premature battery depletion can affect a quarter of subcutaneous cardioverter defibrillators
New atrial fibrillation associated with a high risk of major cardiovascular outcomes
Related Articles
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com